Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

NeuroSearch initiates pivotal Phase III programme with ACR16 for the treatment of Huntington’s disease

Source: www.pipelinereview.com
May 2, 2008
Eurpean phase III study for Huntingdon disease- clinical efficacy for ACR16
Author: GLG Expert Contributor
The news is showing a prospective development to treat Huntingdon's disease, which is  a major neurodegenrative disorder affecting a vast population groups across Europe and USA. As far as the recent treatment option is concerned, complete cure for Huntingdon's disease is not yet found, hence any clinical work to develop drug to treat this disease will be an welcoming addition to the existing...
May 1, 2008
Difficult, but not imposible, trial to complete
Author: GLG Expert Contributor
ACR16 is part of a class of drugs called dopaminergic stabilizers. These drugs modulate the effect of dopamine (a neurotransmitter secreted naturally by the brain). While more effects and interactions related to dopamine are constantly being discovered, it is known that dopamine plays a role in movement disorders such as Huntington’s disease and Parkinson’s disease, amongst others. Huntington’s disease...

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics